Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms
- PMID: 12767108
- DOI: 10.1002/cncr.11382
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms
Abstract
Background: Cancers and cancer treatments produce multiple symptoms that collectively cause a symptom burden for patients. These symptoms include pain, wasting, fatigue, cognitive impairment, anxiety, and depression, many of which co-occur. There is growing recognition that at least some of these symptoms may share common biologic mechanisms.
Methods: In November 2001, basic and clinical scientists met to consider evidence for a cytokine-immunologic model of symptom expression along with directions for future research.
Results: The characteristics of cytokine-induced sickness behavior in animal models have much in common with those of symptomatic cancer patients. Sickness behavior refers to a set of physiologic and behavioral responses observed in animals after the administration of infectious or inflammatory agents or certain proinflammatory cytokines. In some cases, these responses can be prevented by cytokine antagonists. A combination of animal and human research suggests that several cancer-related symptoms may involve the actions of proinflammatory cytokines.
Conclusions: Based on the similarities between cancer symptoms and sickness behavior, the authors discussed approaches to further test the implications of the relationship between inflammatory cytokines and symptoms for both symptom treatment and symptom prevention.
Copyright 2003 American Cancer Society.
Similar articles
-
Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms.Oncol Nurs Forum. 2008 Sep;35(5):802-7. doi: 10.1188/08.ONF.802-807. Oncol Nurs Forum. 2008. PMID: 18765326 Review.
-
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms.Neuroimmunomodulation. 2004;11(5):279-92. doi: 10.1159/000079408. Neuroimmunomodulation. 2004. PMID: 15316238 Review.
-
Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.Neurosci Biobehav Rev. 2005;29(4-5):761-70. doi: 10.1016/j.neubiorev.2005.03.016. Neurosci Biobehav Rev. 2005. PMID: 15878621 Review.
-
The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms.Biol Res Nurs. 2006 Oct;8(2):157-69. doi: 10.1177/1099800406290932. Biol Res Nurs. 2006. PMID: 17003255
-
Cytokines as mediators of depression: what can we learn from animal studies?Neurosci Biobehav Rev. 2005;29(4-5):891-909. doi: 10.1016/j.neubiorev.2005.03.023. Neurosci Biobehav Rev. 2005. PMID: 15885777 Review.
Cited by
-
Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors.Pain Manag Nurs. 2023 Feb;24(1):52-59. doi: 10.1016/j.pmn.2022.09.002. Epub 2022 Oct 10. Pain Manag Nurs. 2023. PMID: 36229337 Free PMC article.
-
A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis.Cells. 2019 Jul 18;8(7):738. doi: 10.3390/cells8070738. Cells. 2019. PMID: 31323874 Free PMC article. Review.
-
Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial.Trials. 2018 Sep 4;19(1):474. doi: 10.1186/s13063-018-2845-7. Trials. 2018. PMID: 30180874 Free PMC article.
-
Genes Involved in the HPA Axis and the Symptom Cluster of Fatigue, Depressive Symptoms, and Anxiety in Women With Breast Cancer During 18 Months of Adjuvant Therapy.Biol Res Nurs. 2020 Apr;22(2):277-286. doi: 10.1177/1099800419899727. Epub 2020 Jan 7. Biol Res Nurs. 2020. PMID: 31908177 Free PMC article.
-
Antidepressant use in ambulatory cancer patients.Curr Oncol Rep. 2006 Jul;8(4):275-81. doi: 10.1007/s11912-006-0033-5. Curr Oncol Rep. 2006. PMID: 17254527 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
